<?xml version="1.0" encoding="UTF-8"?>
<p>When dealing with a possible SARS patient from an endemic TB region, one should never forget TB as a coexisting pathology. In April 2003, a SARS-related hospital screening from Taipei (Taiwan) resulted in discovering 60â€‰TB cases among healthcare workers [
 <xref rid="B27" ref-type="bibr">27</xref>]. Moreover, during the SARS-CoV-1 epidemic from Singapore, SARS cases were reported developing active PTB short after recovering from SARS [
 <xref rid="B25" ref-type="bibr">25</xref>], data compatible with previous studies on mice regarding the suppression of cellular immunity after a viral infection [
 <xref rid="B11" ref-type="bibr">11</xref>]. There is also data on MERS-CoV augmenting TB by the added immunosuppression and reinforcing the need to evaluate a suspected patient [
 <xref rid="B28" ref-type="bibr">28</xref>].
</p>
